Sports
NFLPA demands review of Eagles’ handling of Jalen Hurts’ blood clots
The players’ union says it was told the NFL would not review the medical care Jalen Hurts received, and is seeking a full investigation. The Eagles quarterback is expected to miss the rest of the season after blood clots were found in his lungs.
The NFL Players Association called Tuesday for a full investigation into the medical care Philadelphia Eagles quarterback Jalen Hurts received after blood clots were discovered in his lungs, saying the league had previously told the union it did not plan to review the case.
“Before conclusions are drawn about how this situation was handled, there must be a full investigation into what occurred,” the union said in a statement. It added that establishing the facts is essential to protecting players and ensuring they receive high-quality care.
The demand came hours after NFL chief medical officer Dr. Allen Sills defended the Eagles’ medical staff. A report published Tuesday said the league had concluded the team handled the situation appropriately. The union, however, said it was not aware of any NFL investigation and had been told the league did not intend to examine Hurts’ care.
Hurts, 28, is expected to miss the remainder of the 2026 season. He played in London during Week 5 with what was described as a superficial blood clot in his calf, then traveled back with the team. Further clots were later found in his lungs. He has been placed on injured reserve and is taking blood thinners, which will keep him out for the rest of the year.
A joint statement released Monday by the Eagles and Hurts’ agent, Nicole Lynn, said he was clinically stable and expected to make a full recovery. The NFLPA’s call for an inquiry leaves questions about the sequence of care and the league’s review process unresolved.